MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy

被引:19
作者
Forbes, Sean C.
Lott, Donovan J.
Finkel, Richard S. [2 ]
Senesac, Claudia
Byrne, Barry J. [3 ,4 ]
Sweeney, H. Lee [5 ]
Walter, Glenn A. [6 ]
Vandenborne, Krista [1 ]
机构
[1] Univ Florida, Dept Phys Therapy, UFHSC, Gainesville, FL 32610 USA
[2] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA
[3] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[4] Univ Florida, Powell Gene Therapy Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[5] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA
[6] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA
关键词
Female carrier; Duchenne muscular dystrophy; Magnetic resonance imaging; Magnetic resonance spectroscopy; Skeletal muscle; Biomarker; 6-MINUTE WALK TEST; RELAXATION-TIMES; SKELETAL-MUSCLE; MANIFESTING CARRIER; MRI; EXERCISE; TISSUE; DAMAGE; BOYS; AGE;
D O I
10.1016/j.nmd.2012.05.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to evaluate skeletal muscle composition of lower extremity muscles in a manifesting female carrier of Duchenne muscular dystrophy (MFCDMD) using magnetic resonance imaging (MRI) and spectroscopy (MRS). MRI/MRS was performed on the lower extremities and heart of a MFCDMD (47 years, 51 kg) on four occasions within 21 months and in a control subject. Heterogeneity and asymmetry among muscles in the MFCDMD was observed in lipid fraction and mean transverse relaxation time (T-2) of lower extremity muscles with some muscles presenting as unaffected (e.g., rectus femoris) and others showing substantial deterioration and lipid infiltration (e.g., vasti muscles). There was an association of abnormal MRI findings and strength and motor function. Over the 21 months a small decrease in CSA(max) and increase in lipid fraction and T-2 was observed in the MFCDMD in some muscles. In summary, this MFCDMD revealed significant imaging evidence of pathologic heterogeneity among muscles. Furthermore, this study shows the feasibility of combining various quantitative MRI and MRS approaches to monitor skeletal muscle involvement. Published by Elsevier B.V.
引用
收藏
页码:S111 / S121
页数:11
相关论文
共 50 条
  • [31] Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection
    Alejandra Anaya-Segura, Monica
    Arturo Garcia-Martinez, Froylan
    Angel Montes-Almanza, Luis
    Diaz, Benjamin-Gomez
    Avila-Ramirez, Guillermina
    Alvarez-Maya, Ikuri
    Mauricio Coral-Vazquez, Ramon
    Mondragon-Teran, Paul
    Elena Escobar-Cedillo, Rosa
    Garcia-Calderon, Noemi
    Alejandra Vazquez-Cardenas, Norma
    Garcia, Silvia
    Berenice Lopez-Hernandez, Luz
    MOLECULES, 2015, 20 (06) : 11154 - 11172
  • [32] A MANIFESTING CARRIER OF DUCHENNE MUSCULAR-DYSTROPHY WITH SEVERE MYOCARDIAL SYMPTOMS
    KAMAKURA, K
    KAWAI, M
    ARAHATA, K
    KOIZUMI, H
    WATANABE, K
    SUGITA, H
    JOURNAL OF NEUROLOGY, 1990, 237 (08) : 483 - 485
  • [33] Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: Effects of age and disease progression
    Willcocks, R. J.
    Arpan, I. A.
    Forbes, S. C.
    Lott, D. J.
    Senesac, C. R.
    Senesac, E.
    Deol, J.
    Triplett, W. T.
    Baligand, C.
    Daniels, M. J.
    Sweeney, H. L.
    Walter, G. A.
    Vandenborne, K.
    NEUROMUSCULAR DISORDERS, 2014, 24 (05) : 393 - 401
  • [34] Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy - An MRI study
    Mavrogeni, S
    Tzelepis, GE
    Athanasopoulos, G
    Maounis, T
    Douskou, M
    Papavasiliou, A
    Cokkinos, DV
    CHEST, 2005, 127 (01) : 143 - 148
  • [35] Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy
    Mankodi, Ami
    Bishop, Courtney A.
    Auh, Sungyoung
    Newbould, Rexford D.
    Fischbeck, Kenneth H.
    Janiczek, Robert L.
    NEUROMUSCULAR DISORDERS, 2016, 26 (10) : 650 - 658
  • [36] Xanthine oxidase is hyper-active in Duchenne muscular dystrophy
    Lindsay, Angus
    McCourt, Preston M.
    Karachunski, Peter
    Lowe, Dawn A.
    Ervasti, James M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 129 : 364 - 371
  • [37] Duchenne muscular dystrophy pathophysiology
    Pereon, Y.
    Mercier, S.
    Magot, A.
    ARCHIVES DE PEDIATRIE, 2015, 22 : S18 - S23
  • [38] Duchenne muscular dystrophy: pathogenesis and promising therapies
    Chang, Mengyuan
    Cai, Yong
    Gao, Zihui
    Chen, Xin
    Liu, Boya
    Zhang, Cheng
    Yu, Weiran
    Cao, Qianqian
    Shen, Yuntian
    Yao, Xinlei
    Chen, Xiaoyang
    Sun, Hualin
    JOURNAL OF NEUROLOGY, 2023, 270 (08) : 3733 - 3749
  • [39] Contemporary Cardiac Issues in Duchenne Muscular Dystrophy
    McNally, Elizabeth M.
    Kaltman, Jonathan R.
    Benson, D. Woodrow
    Canter, Charles E.
    Cripe, Linda H.
    Duan, Dongsheng
    Finder, Jonathan D.
    Hoffman, Eric P.
    Judge, Daniel P.
    Kertesz, Naomi
    Kinnett, Kathi
    Kirsch, Roxanne
    Metzger, Joseph M.
    Pearson, Gail D.
    Rafael-Fortney, Jill A.
    Raman, Subha V.
    Spurney, Christopher F.
    Targum, Shari L.
    Wagner, Kathryn R.
    Markham, Larry W.
    CIRCULATION, 2015, 131 (18) : 1590 - 1598
  • [40] A review of evaluation methods for Duchenne muscular dystrophy
    Famili, Zeinab
    Soltanizadeh, Hadi
    Shalbafan, Bita
    MEDICINE IN NOVEL TECHNOLOGY AND DEVICES, 2025, 26